Board of directors of Brazil’s health agency unanimously decided to suspend the temporary authorization for importing and distribution of the Covaxin vaccine, requested by the country’s Health Ministry, according to a statement from the agency.
- Dercision will last until new information is provided to confirm the legal and technical aspects of the authorization
- Decision was taken after Bharat Biotech Limited International, which makes the vaccine, informed that Precisa Medicamentos is no longer authorized to represent the company in Brazil
To see the source of this information, click
Original Story:
To contact ...